X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-05-27 | NXGL | Nexgel, Inc. | Levy Adam R. | CEO | S - Sale | $0.60 | -13,000 | 344,692 | -4% | -$7,834 | |||||
2026-05-28 | SYK | Stryker Corp | Fletcher Robert S | VP, GC | S - Sale | $306.87 | -4,544 | 10,765 | -30% | -$1,394,409 | ||||||
2026-05-27 | NSPR | Inspiremd, Inc. | Stuka Paul | Dir | P - Purchase | $0.88 | +20,000 | 1,091,575 | +2% | +$17,500 | ||||||
| DM | 2026-05-27 | QTEX | Qtrex Quantum Ltd. | Tehila Yafit | CFO | S - Sale+OE | $2.40 | -60,000 | 900,000 | -6% | -$143,961 | |||||
2026-05-26 | SYK | Stryker Corp | Stryker Ronda E | Dir | S - Sale | $312.23 | -310,000 | 14,817,258 | -2% | -$96,792,669 | ||||||
| M | 2026-05-26 | TMCI | Treace Medical Concepts, Inc. | Treace John T. | CEO, 10% | P - Purchase | $2.95 | +115,520 | 12,597,962 | +1% | +$340,589 | |||||
| M | 2026-05-26 | IRMD | Iradimed Corp | Susi Roger E. | CEO, Pres, COB, 10% | S - Sale | $92.14 | -7,500 | 2,165,000 | 0% | -$691,044 | |||||
2026-05-26 | BDX | Becton Dickinson & Co | Feld Michael | EVP, Chief Revenue Officer | S - Sale | $147.35 | -75 | 21,084 | 0% | -$11,051 | ||||||
| M | 2026-05-21 | PDEX | Pro Dex Inc | Van Kirk Richard Lee Jr | CEO | S - Sale | $62.62 | -10,000 | 89,707 | -10% | -$626,248 | |||||
2026-05-21 | BBNX | Beta Bionics, Inc. | Jones Christy | Dir | S - Sale | $9.95 | -1,998 | 30,211 | -6% | -$19,880 | ||||||
| M | 2026-05-21 | BBNX | Beta Bionics, Inc. | Lezack Adam | Dir | S - Sale | $10.58 | -1,998 | 55,796 | -3% | -$21,138 | |||||
| D | 2026-05-21 | CLPT | Clearpoint Neuro, Inc. | Klein Matthew B. | Dir | S - Sale+OE | $11.59 | -16,000 | 46,935 | -25% | -$185,440 | |||||
2026-05-21 | DXCM | Dexcom Inc | Sayer Kevin R | Exec Chair | S - Sale | $72.00 | -26,759 | 382,482 | -7% | -$1,926,648 | ||||||
2026-05-22 | PETV | Petvivo Holdings, Inc. | A.L. Sarroff Fund, LLC | 10% | P - Purchase | $0.40 | +250,000 | 10,452,229 | +2% | +$100,000 | ||||||
| M | 2026-05-25 | BWAY | Brainsway Ltd. | Mitrany Rayten Michal Ety | Dir | S - Sale | $0.00 | -17,980 | 12,500 | -59% | -$0 | |||||
2026-05-22 | ICUI | Icu Medical Inc/De | Woolson Daniel | Pres | S - Sale | $132.21 | -2,123 | 22,479 | -9% | -$280,685 | ||||||
2026-05-20 | ATRC | Atricure, Inc. | Prange Karen | Dir | S - Sale | $28.65 | -3,000 | 26,373 | -10% | -$85,950 | ||||||
2026-05-20 | BSX | Boston Scientific Corp | Pegus Cheryl | Dir | P - Purchase | $56.49 | +1,770 | 1,770 | New | +$99,987 | ||||||
2026-05-20 | BSX | Boston Scientific Corp | Ludwig Edward J | Dir | P - Purchase | $56.68 | +3,580 | 25,359 | +16% | +$202,914 | ||||||
| M | 2026-05-19 | BSX | Boston Scientific Corp | Habiger David C | Dir | P - Purchase | $56.43 | +4,450 | 13,878 | +47% | +$251,098 | |||||
| M | 2025-01-27 | NSPR | Inspiremd, Inc. | Gleason Shane Thomas | Chief Commercial Officer | S - Sale | $2.22 | -85,295 | 1,053,882 | -7% | -$189,594 | |||||
| D | 2026-05-20 | CLPT | Clearpoint Neuro, Inc. | Fallon Lynnette C | Dir | S - Sale+OE | $11.14 | -5,091 | 48,227 | -10% | -$56,714 | |||||
2026-05-20 | LUCD | Lucid Diagnostics Inc. | Matheis Dennis | Dir | P - Purchase | $1.00 | +245,000 | 1,033,443 | +31% | +$245,270 | ||||||
| A | 2026-03-19 | STIM | Neuronetics, Inc. | Pfanstiel Steven | Former EVP, CFO, Treasurer | S - Sale | $1.34 | -8,569 | 836,643 | -1% | -$11,482 | |||||
| D | 2026-05-18 | HTFL | Heartflow, Inc. | Rogers Campbell | Chief Medical Officer | S - Sale+OE | $28.34 | -9,219 | 224,271 | -4% | -$261,266 | |||||
2026-05-18 | KRMD | Koru Medical Systems, Inc. | Schiller Eric | CTO | P - Purchase | $3.91 | +5,000 | 5,000 | New | +$19,563 | ||||||
| M | 2026-05-18 | IRMD | Iradimed Corp | Susi Roger E. | CEO, Pres, COB, 10% | S - Sale | $87.64 | -7,500 | 4,397,950 | 0% | -$657,265 | |||||
2026-05-18 | SIBN | Si-Bone, Inc. | Francis Laura | CEO | S - Sale | $14.71 | -14,957 | 882,126 | -2% | -$220,000 | ||||||
2026-05-18 | SIBN | Si-Bone, Inc. | Pisetsky Michael A. | SVP, Ops, Adm, Chief Legal Ofr | S - Sale | $14.63 | -3,726 | 280,509 | -1% | -$54,527 | ||||||
2026-05-20 | RCEL | Avita Medical, Inc. | O'Toole David D | CFO | P - Purchase | $4.26 | +2,000 | 145,927 | +1% | +$8,520 | ||||||
2026-05-18 | SIBN | Si-Bone, Inc. | Maheshwari Anshul | CFO | S - Sale | $14.69 | -4,666 | 259,877 | -2% | -$68,523 | ||||||
| A | 2026-05-15 | KRMD | Koru Medical Systems, Inc. | Tharby Linda M | CEO | P - Purchase | $3.92 | +1,191 | 620,622 | 0% | +$4,669 | |||||
| E | 2026-05-15 | KRMD | Koru Medical Systems, Inc. | Tharby Linda M | CEO | P - Purchase | $1.00 | +1,191 | 620,622 | 0% | +$1,191 | |||||
2026-05-19 | STIM | Neuronetics, Inc. | Chernett Jorey | 10% | P - Purchase | $1.17 | +100,000 | 10,553,988 | +1% | +$117,000 | ||||||
2026-05-18 | OBIO | Orchestra Biomed Holdings, Inc. | Aryeh Jason | Dir | P - Purchase | $3.75 | +665 | 118,118 | +1% | +$2,494 | ||||||
2026-05-18 | SGHT | Sight Sciences, Inc. | Bauerlein Alison | COO | S - Sale | $5.12 | -12,728 | 688,893 | -2% | -$65,167 | ||||||
2026-05-15 | DXCM | Dexcom Inc | Brown Michael Jon | EVP, GC | S - Sale | $59.91 | -1,700 | 109,504 | -2% | -$101,847 | ||||||
2026-05-19 | RCEL | Avita Medical, Inc. | O'Toole David D | CFO | P - Purchase | $4.24 | +2,000 | 143,927 | +1% | +$8,480 | ||||||
2026-05-15 | TLSI | Trisalus Life Sciences, Inc. | Marshak Richard | Chief Commercial Officer | S - Sale | $2.67 | -543 | 125,101 | 0% | -$1,450 | ||||||
2026-05-15 | INSP | Inspire Medical Systems, Inc. | Rondoni John | See Remarks | S - Sale | $43.28 | -2,641 | 27,165 | -9% | -$114,302 | ||||||
2026-05-15 | OBIO | Orchestra Biomed Holdings, Inc. | Aryeh Jason | Dir | P - Purchase | $3.90 | +8,971 | 117,453 | +8% | +$34,987 | ||||||
2026-05-15 | OBIO | Orchestra Biomed Holdings, Inc. | Hochman David P | See Remarks | P - Purchase | $3.77 | +5,000 | 1,507,651 | 0% | +$18,850 | ||||||
| D | 2026-05-14 | GKOS | Glaukos Corp | Kliman Gilbert H | Dir | S - Sale+OE | $140.76 | -5,000 | 35,528 | -12% | -$703,800 | |||||
2026-05-15 | KMTS | Kestra Medical Technologies, Ltd. | Webster Brian Daniel | See Remarks | S - Sale | $20.96 | -15,000 | 334,786 | -4% | -$314,329 | ||||||
2026-03-14 | BJDX | Bluejay Diagnostics, Inc. | Wurth Douglas Clark | Dir | P - Purchase | $2.00 | +12,500 | 12,608 | >999% | +$25,000 | ||||||
2026-03-14 | BJDX | Bluejay Diagnostics, Inc. | Dey Indranil | Pres, CEO | P - Purchase | $2.00 | +12,500 | 12,649 | >999% | +$25,000 | ||||||
2026-03-14 | BJDX | Bluejay Diagnostics, Inc. | Chase Donald R | Dir | P - Purchase | $2.00 | +12,500 | 12,525 | >999% | +$25,000 | ||||||
2026-03-14 | BJDX | Bluejay Diagnostics, Inc. | Zeidman Fred S | Dir | P - Purchase | $2.00 | +12,500 | 12,500 | New | +$25,000 | ||||||
2026-03-14 | BJDX | Bluejay Diagnostics, Inc. | Dey Svetlana | Dir | P - Purchase | $2.00 | +12,500 | 12,628 | >999% | +$25,000 | ||||||
2026-05-15 | TLSI | Trisalus Life Sciences, Inc. | Wahlstrom Mats | Dir | P - Purchase | $2.53 | +60,000 | 2,962,030 | +2% | +$151,800 | ||||||
2026-05-15 | TLSI | Trisalus Life Sciences, Inc. | Stansky Michael P | Dir | P - Purchase | $2.50 | +610,000 | 1,640,420 | +59% | +$1,525,000 | ||||||
2026-05-15 | TLSI | Trisalus Life Sciences, Inc. | Szela Mary T | CEO, Pres | P - Purchase | $2.59 | +39,682 | 1,065,215 | +4% | +$102,776 | ||||||
2026-05-15 | TLSI | Trisalus Life Sciences, Inc. | Patience David | CFO | P - Purchase | $2.43 | +7,100 | 275,757 | +3% | +$17,253 | ||||||
2026-05-15 | TLSI | Trisalus Life Sciences, Inc. | Gordon Gary B. | Dir | P - Purchase | $2.46 | +10,000 | 72,510 | +16% | +$24,600 | ||||||
2026-05-14 | KRMD | Koru Medical Systems, Inc. | Pazdan Christopher | COO | P - Purchase | $3.88 | +5,000 | 305,131 | +2% | +$19,400 | ||||||
2026-05-14 | KRMD | Koru Medical Systems, Inc. | Adams Thomas Edward | CFO | P - Purchase | $3.86 | +5,500 | 308,147 | +2% | +$21,248 | ||||||
2026-05-15 | ATRC | Atricure, Inc. | Doraiswamy Vinayak | Chief Scientific Officer | S - Sale | $28.13 | -5,000 | 91,875 | -5% | -$140,650 | ||||||
| M | 2026-04-15 | ECIA | Encision Inc | Fries Robert H | CEO | P - Purchase | $0.14 | +166,785 | 1,506,785 | +12% | +$24,025 | |||||
2026-05-14 | OBIO | Orchestra Biomed Holdings, Inc. | Fain Eric S | Dir | P - Purchase | $4.13 | +20,000 | 91,709 | +28% | +$82,600 | ||||||
| A | 2026-05-11 | PLSE | Pulse Biosciences, Inc. | Duggan Robert W | Dir, 10% | P - Purchase | $19.69 | +660,233 | 49,450,345 | +1% | +$12,999,988 | |||||
2026-05-14 | INSP | Inspire Medical Systems, Inc. | Rondoni John | See Remarks | S - Sale | $43.01 | -700 | 29,806 | -2% | -$30,107 | ||||||
| M | 2026-05-13 | NSPR | Inspiremd, Inc. | Stuka Paul | Dir | P - Purchase | $1.16 | +15,000 | 1,071,575 | +1% | +$17,325 | |||||
2026-05-14 | ICUI | Icu Medical Inc/De | Sanzone Virginia Ruth | VP, GC | S - Sale | $124.08 | -2,447 | 19,460 | -11% | -$303,624 | ||||||
| M | 2026-05-12 | OSUR | Orasure Technologies Inc | Boyd Steven Kyle | Dir | P - Purchase | $3.00 | +75,000 | 113,462 | +195% | +$224,750 | |||||
| M | 2026-05-12 | TMCI | Treace Medical Concepts, Inc. | Treace John T. | CEO, 10% | P - Purchase | $2.44 | +153,763 | 12,482,442 | +1% | +$375,505 | |||||
2026-05-12 | DXCM | Dexcom Inc | Heller Bridgette P | Dir | S - Sale | $60.01 | -1,012 | 25,007 | -4% | -$60,730 | ||||||
| D | 2026-05-12 | ICUI | Icu Medical Inc/De | Greenberg David C. | Dir | S - Sale+OE | $122.91 | -2,424 | 9,214 | -21% | -$297,934 | |||||
| D | 2026-05-11 | GKOS | Glaukos Corp | Kliman Gilbert H | Dir | S - Sale+OE | $135.00 | -5,000 | 35,528 | -12% | -$675,000 | |||||
2026-05-11 | HTFL | Heartflow, Inc. | Farquhar John C.M. | CEO | S - Sale | $29.12 | -22,562 | 519,397 | -4% | -$657,005 | ||||||
2026-05-12 | UFPT | Ufp Technologies Inc | Croteau Daniel C | Dir | S - Sale | $221.71 | -2,864 | 855 | -77% | -$634,977 | ||||||
2026-05-11 | TCMD | Tactile Systems Technology Inc | Birkemeyer Elaine M. | CFO | S - Sale | $24.49 | -4,631 | 130,188 | -3% | -$113,404 | ||||||
2026-05-12 | NSPR | Inspiremd, Inc. | Slosman Marvin | CEO, Pres | P - Purchase | $1.20 | +21,000 | 3,556,658 | +1% | +$25,200 | ||||||
| AM | 2026-05-08 | NSPR | Inspiremd, Inc. | Stuka Paul | Dir | P - Purchase | $1.16 | +75,626 | 1,056,575 | +8% | +$88,026 | |||||
| M | 2026-05-11 | IRMD | Iradimed Corp | Susi Roger E. | CEO, Pres, COB, 10% | S - Sale | $84.18 | -7,500 | 4,405,450 | 0% | -$631,341 | |||||
| D | 2026-05-11 | MMSI | Merit Medical Systems Inc | Smith Christian Adam | Chief Commercial Officer | P - Purchase | $61.00 | +1,626 | 32,554 | +5% | +$99,186 | |||||
2026-05-12 | STIM | Neuronetics, Inc. | Chernett Jorey | 10% | P - Purchase | $1.34 | +475,000 | 10,453,988 | +5% | +$636,500 | ||||||
| M | 2026-05-08 | NSPR | Inspiremd, Inc. | Stuka Paul | Dir | P - Purchase | $1.16 | +75,626 | 1,056,575 | +8% | +$88,026 | |||||
| D | 2026-05-11 | IRTC | Irhythm Holdings, Inc. | Talwalkar Abhijit Y | Dir | P - Purchase | $10.71 | +5,312 | 20,299 | +35% | +$56,892 | |||||
| D | 2026-05-11 | IRTC | Irhythm Holdings, Inc. | Talwalkar Abhijit Y | Dir | S - Sale+OE | $117.93 | -5,312 | 20,299 | -21% | -$626,430 | |||||
| D | 2026-05-11 | SYK | Stryker Corp | Fink M Kathryn | VP, CHRO | S - Sale+OE | $283.69 | -8,720 | 13,758 | -39% | -$2,473,756 | |||||
| D | 2026-05-11 | MOBI | Mobia Medical, Inc. | Osage University Gp Iii, LLC | 10% | P - Purchase | $15.00 | +533,333 | 1,404,183 | +61% | +$7,999,995 | |||||
2026-05-12 | SRTS | Sensus Healthcare, Inc. | Sachetta Eric | Dir | P - Purchase | $3.34 | +1,500 | 145,706 | +1% | +$5,003 | ||||||
2026-05-08 | INFU | Infusystem Holdings, Inc | Gendron Paul Andrew | Dir | P - Purchase | $8.88 | +5,000 | 70,000 | +8% | +$44,400 | ||||||
| M | 2026-05-08 | INFU | Infusystem Holdings, Inc | Lachance Carrie | Pres, CEO | P - Purchase | $8.71 | +3,000 | 473,246 | +1% | +$26,120 | |||||
2026-05-08 | INFU | Infusystem Holdings, Inc | Steele Barry G | EVP, CFO | P - Purchase | $8.71 | +7,000 | 186,180 | +4% | +$60,949 | ||||||
| D | 2026-05-11 | MOBI | Mobia Medical, Inc. | Tansey Casey M | Dir, 10% | P - Purchase | $15.00 | +66,666 | 3,860,158 | +2% | +$999,990 | |||||
| D | 2026-05-11 | MOBI | Mobia Medical, Inc. | Harrington William T | Dir, 10% | P - Purchase | $15.00 | +533,333 | 1,404,183 | +61% | +$7,999,995 | |||||
| D | 2026-05-11 | MOBI | Mobia Medical, Inc. | Lucchese Cynthia L | Dir | P - Purchase | $15.00 | +125,000 | 125,000 | New | +$1,875,000 | |||||
| D | 2026-05-11 | MOBI | Mobia Medical, Inc. | Leavitt Chase C. | See Remarks | P - Purchase | $15.00 | +3,000 | 3,000 | New | +$45,000 | |||||
| D | 2026-05-11 | MOBI | Mobia Medical, Inc. | Mead Dana G Jr. | Dir | P - Purchase | $15.00 | +7,000 | 7,000 | New | +$105,000 | |||||
| A | 2026-05-11 | PLSE | Pulse Biosciences, Inc. | Laviolette Paul A | CEO | P - Purchase | $19.69 | +15,000 | 15,846 | >999% | +$295,350 | |||||
| M | 2026-05-07 | ATEC | Alphatec Holdings, Inc. | Valentine Keith | Dir | P - Purchase | $7.38 | +135,000 | 232,271 | +139% | +$996,192 | |||||
2026-05-11 | PLSE | Pulse Biosciences, Inc. | Laviolette Paul A | CEO | P - Purchase | $19.69 | +15,000 | 15,000 | New | +$295,350 | ||||||
2026-05-11 | PLSE | Pulse Biosciences, Inc. | Duggan Robert W | Dir, 10% | P - Purchase | $19.69 | +660,233 | 49,291,731 | +1% | +$12,999,988 | ||||||
| M | 2026-05-07 | LMAT | Lemaitre Vascular Inc | Lemaitre George W | COB, CEO | S - Sale | $108.27 | -46,481 | 1,463,419 | -3% | -$5,032,413 | |||||
2026-05-08 | LMAT | Lemaitre Vascular Inc | Kamke Trent G | Senior V. P., Operations | S - Sale | $107.00 | -2,928 | 3,749 | -44% | -$313,287 | ||||||
| D | 2026-05-07 | LMAT | Lemaitre Vascular Inc | Ross Bridget A | Dir | S - Sale+OE | $111.10 | -5,044 | 3,942 | -56% | -$560,366 | |||||
| D | 2026-05-07 | LMAT | Lemaitre Vascular Inc | Jasinski Lawrence J | Dir | S - Sale+OE | $110.00 | -3,943 | 4,714 | -46% | -$433,730 | |||||
2026-05-08 | INSP | Inspire Medical Systems, Inc. | McCormick Shawn | Dir | S - Sale | $45.31 | -696 | 30,712 | -2% | -$31,536 | ||||||
2026-05-11 | RDGL | Vivos Inc | Korenko Michael K | CEO, Pres | P - Purchase | $0.06 | +150,000 | 11,085,090 | +1% | +$9,270 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |